SCHEMBL20109143

SCHEMBL20109143

CCCC/C(CC)=C(\CC)P1(=O)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.35
RIN1 Q13671 1/20 0.35
LMNA P02545 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
PLA2G1B P04054 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
MAPK1 P28482 2/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 3/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
PTGS2 P35354 2/20 0.33
SHMT2 P34897 1/20 0.32
DRD2 P14416 1/20 0.32
SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109338 0.85 GAA (0.34) LMNANPSR1PLA2G1BTSHRKMT2A
SCHEMBL20109218 0.84 LMNA (0.33) ABL1RIN1LMNANPSR1PLA2G1B
SCHEMBL20109246 0.84 LMNA (0.33) ABL1RIN1LMNANPSR1PLA2G1B
SCHEMBL20113435 0.77 MAPT (0.36) LMNANPSR1PLA2G1BTSHRKMT2A
SCHEMBL20113630 0.74 GAA (0.34) LMNANPSR1PLA2G1BTSHRKMT2A
SCHEMBL20109140 0.72 CHRNA7 (0.36) LMNANPSR1TSHRKMT2AALOX15
SCHEMBL20109139 0.71 MAPT (0.36) LMNANPSR1TSHRKMT2AMAPK1
SCHEMBL20109133 0.68 TSHR (0.40) LMNATSHRKMT2AMAPK1ALOX15
SCHEMBL20109155 0.67 DRD2 (0.33) KMT2AMAPTDRD2SIGMAR1ALDH1A1
SCHEMBL20587771 0.67 MEN1 (0.41) LMNANPSR1TSHRKMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 ABL1 2429/4885RIN1 1346/4885LMNA 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.